Monitoring of cellular resistance to cancer chemotherapy: drug retention and efflux.
Krishan
A
A
Radiation Oncology Department, University of Miami School of Medicine, Florida 33136, USA.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000378:metabolism / Q000493:pharmacokinetics*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002463:Cell Membrane Permeability; D002746:Chlorpromazine / Q000494:pharmacology; D003630:Daunorubicin / Q000493:pharmacokinetics / Q000494:pharmacology; D004317:Doxorubicin / Q000493:pharmacokinetics / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005434:Flow Cytometry / Q000295:instrumentation / Q000379:methods*; D005456:Fluorescent Dyes / Q000378:metabolism; D006801:Humans; D051379:Mice; D020112:Rhodamine 123 / Q000378:metabolism; D013194:Staining and Labeling; D014407:Tumor Cells, Cultured; D014700:Verapamil / Q000494:pharmacology
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D002121:Calcium Channel Blockers; D005456:Fluorescent Dyes; D020112:Rhodamine 123; D004317:Doxorubicin; D014700:Verapamil; D002746:Chlorpromazine; D003630:Daunorubicin